Dilemmas in treating smoldering multiple myeloma

Inhye E. Ahn, Sham Mailankody, Neha Korde, Ola Landgren

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations

Abstract

Novel therapies hold promise for high-risk smoldering multiple myeloma (SMM). Recent studies suggest that modern combination approaches can be options for high-risk SMM to obtain deep molecular responses with favorable toxicity profiles. Although pioneering treatment trials based on small numbers of patients suggest progression-free and overall survival benefits, application of the data to real-life practice remains to be validated. Therapeutic modulation of disease tempo, disease burden, clonal evolution, and tumor microenvironment in SMM remains to be understood and calls for reliable biomarkers reflective of disease biology. Here, we review studies that open a new management platform for SMM, address ongoing dilemmas in practice and under investigation, and highlight emerging scientific questions in the era of SMM treatment.

Original languageEnglish (US)
Pages (from-to)115-123
Number of pages9
JournalJournal of Clinical Oncology
Volume33
Issue number1
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Dilemmas in treating smoldering multiple myeloma'. Together they form a unique fingerprint.

Cite this